Atomoxetine and Methylphenidate Treatment in ADHD

1. Kooij SJ, Bejerot S, Blackwell A et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 2010; 10:67.10.1186/1471-244X-10-67Search in Google Scholar

2. Stein MA. Impairment associated with adult ADHD. CNS Spectr 2008; 13 (12) :9-1.10.1017/S1092852900003187Search in Google Scholar

3. Arnsten AF, Li BM. Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions. Biological Psychiatry 2005; 57 (11): 1377-84.10.1016/j.biopsych.2004.08.019Search in Google Scholar

4. Bolden-Watson C, Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993; 52 (12): 1023-9.10.1016/0024-3205(93)90194-8Search in Google Scholar

5.Grizenko N, Bhat M, Schwartz G, Ter-Stepanian M,Joober R.Efficacyofmethylphenidate in childrenwithat ten - tion-deficithyperactivitydisorder and learningdisabilities: a randomizedcrossover trial. J PsychiatryNeurosci. 2006; 31(1): 46-51.Search in Google Scholar

6. Kratochvil CJ, Heiligenstein JH, Dittmann R, Spencer TJ, Biederman J, Wernicke J, Newcorn JH, Casat C, Milton D, Michelson D. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 2002; 41(7): 776-84.10.1097/00004583-200207000-0000812108801Search in Google Scholar

7. Yildiz O, Sismanlar SG, Memik NC, Karakaya I, AgaogluB.Atomoxetine and Methylphenidate Treatment in Children with ADHD: The Efficacy, Tolerability and Effects on Executive Functions. Child Psychiatry & Human Development 2011; 42 (3): 257-269.10.1007/s10578-010-0212-321165694Search in Google Scholar

8. Garg J, Arun P, ChavanBS. Comparativeshort term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder. Indian Pediatr. 2014; 51: 550-554.10.1007/s13312-014-0445-525031133Search in Google Scholar

9. Lv XZ, Shu Z, Zhang YW, Wu SS, Zhan SY. Effectiveness and safety of methylphenidate and atomoxetine for attention deficit hyperactivity disorder: a systematic review. Transl Pediatr 2012; 1: 47-53.Search in Google Scholar

10. Gibdon AP, Bettinger TL, Patel NC, Crismon ML. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann Pharmacother 2006; 40 (6) :1134-42.10.1345/aph.1G58216735655Search in Google Scholar

11. Hanwella R, Senanayake M, Silva V. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a metaanalysis. BMC Psychiatry 2011; 11: 168-176.10.1186/1471-244X-11-176322945922074258Search in Google Scholar

12. Ghuman JK, Breitborde NJK.Review: methylphenidate and atomoxetine have similar efficacy and acceptability in children and adolescents with ADHD Evid Based Mental Health 2012; 15: 68-74.Search in Google Scholar

13. Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 2008; 165 (6):721-30.10.1176/appi.ajp.2007.0509167618281409Search in Google Scholar